HK1111624A1 - Stable formulation comprising a moisture sensitve drug and manufacturing procedure thereof - Google Patents

Stable formulation comprising a moisture sensitve drug and manufacturing procedure thereof

Info

Publication number
HK1111624A1
HK1111624A1 HK08105934A HK08105934A HK1111624A1 HK 1111624 A1 HK1111624 A1 HK 1111624A1 HK 08105934 A HK08105934 A HK 08105934A HK 08105934 A HK08105934 A HK 08105934A HK 1111624 A1 HK1111624 A1 HK 1111624A1
Authority
HK
Hong Kong
Prior art keywords
sensitve
drug
moisture
manufacturing procedure
stable formulation
Prior art date
Application number
HK08105934A
Other languages
English (en)
Inventor
Fox Michael
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HK1111624A1 publication Critical patent/HK1111624A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
HK08105934A 2006-06-02 2008-05-28 Stable formulation comprising a moisture sensitve drug and manufacturing procedure thereof HK1111624A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06252877A EP1864677B1 (en) 2006-06-02 2006-06-02 Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof

Publications (1)

Publication Number Publication Date
HK1111624A1 true HK1111624A1 (en) 2008-08-15

Family

ID=37307222

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08105934A HK1111624A1 (en) 2006-06-02 2008-05-28 Stable formulation comprising a moisture sensitve drug and manufacturing procedure thereof

Country Status (6)

Country Link
EP (2) EP1917973A1 (xx)
DE (1) DE602006000402T8 (xx)
DK (1) DK1864677T3 (xx)
ES (1) ES2299157T3 (xx)
HK (1) HK1111624A1 (xx)
PT (1) PT1864677E (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433018B1 (en) * 2001-08-31 2002-08-13 The Research Foundation Of State University Of New York Method for reducing hypertrophy and ischemia
WO2009118760A2 (en) * 2008-03-26 2009-10-01 Matrix Laboratories Limited Lanthanum composition
DE102008020701A1 (de) * 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128984B (en) 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
WO2003075842A2 (en) * 2002-03-08 2003-09-18 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor

Also Published As

Publication number Publication date
EP1864677B1 (en) 2008-01-02
EP1917973A1 (en) 2008-05-07
DE602006000402T2 (de) 2008-12-11
DK1864677T3 (da) 2008-04-28
DE602006000402D1 (de) 2008-02-28
PT1864677E (pt) 2008-03-13
EP1864677A1 (en) 2007-12-12
ES2299157T3 (es) 2008-05-16
DE602006000402T8 (de) 2009-04-09

Similar Documents

Publication Publication Date Title
EP2084519A4 (en) ADVANCED PRODUCTION AND MANUFACTURE OF MEDICINES
EP2081550A4 (en) COATING CAPSULES WITH ACTIVE PHARMACEUTICAL INGREDIENTS
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
ZA200809998B (en) Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
EP1909772A4 (en) TRANSDERMAL DRUG FORMULATION
EP2080242A4 (en) TOPOSCOPIC ACCESS AND ACCESS DEVICES
IL198046A (en) Metastatin derivatives and drugs that include them
PL1850664T3 (pl) Formulacja kapsułki pestycydowej
PT1957073E (pt) Medicamento
GB0625963D0 (en) Medicaments and methods for wound healing
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medications and medications containing them
ZA200706495B (en) Tablets with improved drug substance dispersibility
IL194751A0 (en) Drugs and uses
GB0614586D0 (en) Pharmaceutical Formulation
EP2045253A4 (en) alpha-amino acid derivative and pharmaceutical agent containing it as an active ingredient
ZA200808162B (en) Active ingredient combinations with insecticidal properties
GB2443336B (en) Spiruchostatin analogues and their medicinal use
IL193700A0 (en) Medicaments and proteins
HK1111624A1 (en) Stable formulation comprising a moisture sensitve drug and manufacturing procedure thereof
EP1871344A4 (en) INHIBITABLE MEDICINAL PRODUCT
IL195060A0 (en) Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
ZA200804086B (en) Stable pharmaceutical formulations containing escitalo-pram and bupropion
IL196273A0 (en) Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
GB0613761D0 (en) A pharmaceutical formulation and method for the preparation thereof
EP1941054A4 (en) DEVELOPMENT OF ANTHELMINTHIC AND / OR AN INSECTICIDE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120602